Brookfield Co. (NYSE:BN – Get Free Report) was the target of a large growth in short interest in the month of September. As of September 15th, there was short interest totalling 11,390,000 shares, a growth of 10.3% from the August 31st total of 10,330,000 shares. Currently, 0.9% of the shares of the company are short sold. Based on an average trading volume of 3,310,000 shares, the days-to-cover ratio is currently 3.4 days.
Wall Street Analyst Weigh In
A number of equities analysts recently weighed in on the stock. BMO Capital Markets lifted their price objective on shares of Brookfield from $48.00 to $50.00 and gave the company an “outperform” rating in a research report on Wednesday, September 11th. Royal Bank of Canada lowered their price objective on shares of Brookfield from $57.00 to $56.00 and set an “outperform” rating on the stock in a research report on Friday, August 9th. Scotiabank lifted their price objective on shares of Brookfield from $50.50 to $51.25 and gave the company a “sector outperform” rating in a research report on Friday, August 9th. Keefe, Bruyette & Woods lifted their price objective on shares of Brookfield from $44.00 to $46.00 and gave the company a “market perform” rating in a research report on Friday, August 9th. Finally, TD Securities lifted their price objective on shares of Brookfield from $62.00 to $63.00 and gave the company a “buy” rating in a research report on Monday, August 12th. Two investment analysts have rated the stock with a hold rating and six have given a buy rating to the company. According to MarketBeat, Brookfield currently has a consensus rating of “Moderate Buy” and an average price target of $51.59.
View Our Latest Stock Report on BN
Institutional Investors Weigh In On Brookfield
Brookfield Price Performance
Shares of NYSE BN traded down $0.06 during trading on Tuesday, hitting $53.09. 1,894,559 shares of the company were exchanged, compared to its average volume of 3,019,372. The company has a market cap of $87.26 billion, a price-to-earnings ratio of 87.03 and a beta of 1.53. Brookfield has a 1 year low of $28.84 and a 1 year high of $54.29. The firm’s fifty day moving average price is $48.35 and its 200 day moving average price is $44.44. The company has a debt-to-equity ratio of 1.39, a current ratio of 1.20 and a quick ratio of 1.03.
Brookfield (NYSE:BN – Get Free Report) last released its quarterly earnings data on Thursday, August 8th. The company reported $1.35 EPS for the quarter, topping the consensus estimate of $0.78 by $0.57. Brookfield had a net margin of 1.13% and a return on equity of 3.67%. The business had revenue of $23.05 billion for the quarter, compared to analyst estimates of $1.24 billion. During the same period in the previous year, the firm earned $0.75 EPS. The business’s revenue for the quarter was down 2.6% compared to the same quarter last year. On average, sell-side analysts expect that Brookfield will post 3.84 earnings per share for the current fiscal year.
Brookfield Dividend Announcement
The firm also recently disclosed a quarterly dividend, which was paid on Friday, September 27th. Investors of record on Thursday, September 12th were given a $0.08 dividend. The ex-dividend date was Thursday, September 12th. This represents a $0.32 annualized dividend and a dividend yield of 0.60%. Brookfield’s dividend payout ratio is presently 52.46%.
Brookfield Company Profile
Brookfield Corporation is an alternative asset manager and REIT/Real Estate Investment Manager firm focuses on real estate, renewable power, infrastructure and venture capital and private equity assets. It manages a range of public and private investment products and services for institutional and retail clients.
See Also
- Five stocks we like better than Brookfield
- Top Stocks Investing in 5G Technology
- Why Lennar Stock Could Be the Best Play in the Housing Market
- What to Know About Investing in Penny Stocks
- 2 Energy Stocks Fueling the AI Datacenter Boom
- Insider Selling Explained: Can it Inform Your Investing Choices?
- Will Marinus Pharmaceuticals Be the Next Big Winner in Biotech?
Receive News & Ratings for Brookfield Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Brookfield and related companies with MarketBeat.com's FREE daily email newsletter.